Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03669224
Other study ID # CEBD-CU-2018-09-04
Secondary ID
Status Completed
Phase Phase 1
First received
Last updated
Start date November 1, 2019
Est. completion date March 19, 2021

Study information

Verified date March 2021
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study to detect the effect of Nano Care Gold on marginal integrity of resin composite restoration


Description:

This study will be divided into 3 groups (control, Nano Care Gold, Chlorhexidine). Both materials will be used as a surface pre-treatment. Their effect on marginal integrity will be evaluated through evaluation of marginal adaptation, marginal staining, post-operative sensitivity. The follow up period is one year


Recruitment information / eligibility

Status Completed
Enrollment 57
Est. completion date March 19, 2021
Est. primary completion date March 19, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 17 Years to 50 Years
Eligibility Inclusion Criteria: - (1) Patients with at least two class II cavities (2) 17-50 years old (3) Males or females (4) Good or hygiene (5) Good general health (6) Cooperative patients (7) Subjects who signed the informed consent Exclusion Criteria: 1. Patients younger than 17 years or older than 50 years old 2. Pregnant females 3. Disabilities 4. Systemic disease or severe medical complications 5. Heavy smoking 6. Lack of compliance

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Nano Care Gold
Mixture of Gold and Silver nano particles suspended in 70 % Isopropyl alcohol. This group will be compared with no intervention group.
No intervention
No intervention will be applied in this group. It will be the negative comparator. In this group only the standard of care will be applied, which means the steps will be cavity preparation followed by adhesive system then resin composite without any surface pre-treatment
Chlorhexidine
2 % chlorhexidine gluconate. This group will be compared with no intervention group.

Locations

Country Name City State
Egypt Aya Abd El-Fattah Mohammed Nemtallah Maadi Cairo

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Marginal adaptation It will be measured by FDI probe and Digora x-ray machine. FDI Scoring system (categorical) 5 steps(3 accepted, 2 unaccepted) will be used to evaluate the outcome of measuring device 1 year
Secondary Marginal staining Visual inspection and Photographs will be used to measure the outcome. FDI Scoring system(categorical) 5 steps(3 accepted, 2 unaccepted) will be used to evaluate the outcome 1 year
Secondary Post operative sensitivity A blast of cold air will be used to evaluate the restoration. FDI Scoring system(categorical) 5 steps(3 accepted, 2 unaccepted) will be used to determine the restoration fit in which category. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05020093 - Clinical Performance of Injection-Molding Vs. Incremental Packing of Resin Composite in Cavitated Posterior Teeth N/A
Completed NCT04019145 - Clinical Evaluation of Fiber Reinforced Resin Composite Base Versus Incremental Packing of Nanohybrid Resin Composite Early Phase 1
Recruiting NCT04720638 - Clinical Performance of Short Fiber Reinforced Flowable Resin Composite Restorations 2y RCT N/A
Not yet recruiting NCT04900246 - Evaluation of Different Methods for the Diagnosis of Primary Caries Lesions Phase 1
Recruiting NCT04790383 - Clinical Performance of Advanced Self- Adhesivee Resin Composite Hybrid Restorations. N/A
Not yet recruiting NCT05949502 - Evaluation of Performance and Occlusal Wear of Low Shrinkage Giomer Compared to Nanohybrid Resin Composite N/A